Cipla to Launch MannKind's Innovative Inhaled Insulin in Indian Market
You May Interested In
2026-07-25
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Profit Crushed, Layoffs and Restructuring Follow: What WACKER Chemie’s 2025 Performance Reveals
-
Brenntag Expands Distribution of Givaudan’s Active Beauty Ingredients to Malaysia and Singapore
-
When the Chemical Industry Is No Longer Highly Profitable: Sinochem International’s 2.4 Billion Yuan Loss Reveals the Truth About Industry Cycles
-
Paint Giant PPG Announces Global Price Hike
-
“The Agency Revolution”: BASF Breaks Into Dongfeng Liuzhou’s Supply Chain
-
Wanhua Chemical's Fujian 800,000 t/y MDI Plant Undergoes Scheduled Maintenance
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
-
Titanium Dioxide: Stuck Between Weak Upside and Limited Downside
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
Recommend Reading
-
Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?
-
BASF and Zhejiang University Forge Innovation Partnership
-
ADNOC Advances Covestro Deal Amid EU Subsidy Probe
-
NHU and Sinopec Advance Liquid Methionine Project
-
Mitsui Chemicals Restarts TDI Plant After Accident Shutdown
-
This Weekend, the Chinese Hydrofluoric Acid Market Experienced a Slight Decline (6.22-6.26)
-
The Game Between Costs and Demand: Melamine Remains Stable
-
Both Supply and Demand Weak, Butadiene Market Downward
-
MTBE Market Prices Continue to Decline
-
Sodium Benzoate (E211): Safety, Benzene Risk, and Preservative Uses